89 related articles for article (PubMed ID: 9495080)
1. [Risk factors for mortality in patients with insulin-dependent diabetes].
Rossing P; Hougaard P; Borch-Johnsen K; Parving HH
Ugeskr Laeger; 1998 Feb; 160(9):1315-9. PubMed ID: 9495080
[TBL] [Abstract][Full Text] [Related]
2. [Albuminuria and glycemic control. The significance for mortality in non-insulin-dependent diabetes mellitus].
Gall MA; Borch-Johnsen K; Hougaard P; Nielsen FS; Parving HH
Ugeskr Laeger; 1996 Nov; 158(48):6907-11. PubMed ID: 8984753
[TBL] [Abstract][Full Text] [Related]
3. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study.
Rossing P; Hougaard P; Borch-Johnsen K; Parving HH
BMJ; 1996 Sep; 313(7060):779-84. PubMed ID: 8842069
[TBL] [Abstract][Full Text] [Related]
4. [Significant risk factors for development of microalbuminuria and diabetic nephropathy in patients with non-insulin-dependent diabetes].
Gall ML; Hougaard P; Borch-Johnsen K; Parving HH
Ugeskr Laeger; 1998 Jul; 160(31):4524-7. PubMed ID: 9700308
[TBL] [Abstract][Full Text] [Related]
5. High-normal levels of albuminuria predict the development of micro- and macroalbuminuria and increased mortality in Brazilian Type 2 diabetic patients: an 8-year follow-up study.
Murussi M; Campagnolo N; Beck MO; Gross JL; Silveiro SP
Diabet Med; 2007 Oct; 24(10):1136-42. PubMed ID: 17561963
[TBL] [Abstract][Full Text] [Related]
6. [Microalbuminuria--a valuable diagnostic parameter].
Feldt-Rasmussen BF; Borch-Johnsen K; Deckert T; Jensen G; Jensen JS
Ugeskr Laeger; 1993 Dec; 155(51):4149-54. PubMed ID: 8273236
[TBL] [Abstract][Full Text] [Related]
7. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes.
Donnelly R; Yeung JM; Manning G
J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161
[TBL] [Abstract][Full Text] [Related]
8. Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria.
Gaede P; Tarnow L; Vedel P; Parving HH; Pedersen O
Nephrol Dial Transplant; 2004 Nov; 19(11):2784-8. PubMed ID: 15328385
[TBL] [Abstract][Full Text] [Related]
9. Twelve shifting paradigms in diabetic renal disease and hypertension.
Mogensen CE
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897
[TBL] [Abstract][Full Text] [Related]
10. Effects of aerobic exercise on microalbuminuria and enzymuria in type 2 diabetic patients.
Lazarevic G; Antic S; Vlahovic P; Djordjevic V; Zvezdanovic L; Stefanovic V
Ren Fail; 2007; 29(2):199-205. PubMed ID: 17365936
[TBL] [Abstract][Full Text] [Related]
11. Prediction of cardiovascular and total mortality in Chinese type 2 diabetic patients by the WHO definition for the metabolic syndrome.
Ko GT; So WY; Chan NN; Chan WB; Tong PC; Li J; Yeung V; Chow CC; Ozaki R; Ma RC; Cockram CS; Chan JC
Diabetes Obes Metab; 2006 Jan; 8(1):94-104. PubMed ID: 16367887
[TBL] [Abstract][Full Text] [Related]
12. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
Saraheimo M; Forsblom C; Thorn L; Wadén J; Rosengård-Bärlund M; Heikkilä O; Hietala K; Gordin D; Frystyk J; Flyvbjerg A; Groop PH;
Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990
[TBL] [Abstract][Full Text] [Related]
13. Increased circulating CD31+/annexin V+ apoptotic microparticles and decreased circulating endothelial progenitor cell levels in hypertensive patients with microalbuminuria.
Huang PH; Huang SS; Chen YH; Lin CP; Chiang KH; Chen JS; Tsai HY; Lin FY; Chen JW; Lin SJ
J Hypertens; 2010 Aug; 28(8):1655-65. PubMed ID: 20520578
[TBL] [Abstract][Full Text] [Related]
14. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients with left ventricular hypertrophy and diabetes.
Ibsen H; Olsen MH; Wachtell K; Borch-Johnsen K; Lindholm LH; Mogensen CE
J Nephrol; 2008; 21(4):566-9. PubMed ID: 18651547
[TBL] [Abstract][Full Text] [Related]
15. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
[TBL] [Abstract][Full Text] [Related]
16. Mannose-binding lectin and mortality in type 2 diabetes.
Hansen TK; Gall MA; Tarnow L; Thiel S; Stehouwer CD; Schalkwijk CG; Parving HH; Flyvbjerg A
Arch Intern Med; 2006 Oct; 166(18):2007-13. PubMed ID: 17030835
[TBL] [Abstract][Full Text] [Related]
17. Microalbuminaria and the risk of atherosclerosis. Clinical epidemiological and physiological investigations.
Jensen JS
Dan Med Bull; 2000 Apr; 47(2):63-78. PubMed ID: 10822799
[TBL] [Abstract][Full Text] [Related]
18. Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex.
Raile K; Galler A; Hofer S; Herbst A; Dunstheimer D; Busch P; Holl RW
Diabetes Care; 2007 Oct; 30(10):2523-8. PubMed ID: 17630266
[TBL] [Abstract][Full Text] [Related]
19. Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study.
Astrup AS; Nielsen FS; Rossing P; Ali S; Kastrup J; Smidt UM; Parving HH
J Hypertens; 2007 Dec; 25(12):2479-85. PubMed ID: 17984670
[TBL] [Abstract][Full Text] [Related]
20. Diabetes mellitus--long time survival.
Muller WA
J Insur Med; 1998; 30(1):17-27. PubMed ID: 10186435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
